IRIS
MADEDDU, Giordano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.720
EU - Europa 4.007
AS - Asia 1.792
SA - Sud America 82
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 20
AF - Africa 18
Totale 10.664
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.675
IT - Italia 1.750
UA - Ucraina 976
CN - Cina 854
SG - Singapore 804
DE - Germania 436
SE - Svezia 177
FI - Finlandia 166
FR - Francia 157
GB - Regno Unito 105
BR - Brasile 75
CZ - Repubblica Ceca 56
CA - Canada 38
RO - Romania 36
BE - Belgio 35
KR - Corea 30
TR - Turchia 30
AU - Australia 24
RU - Federazione Russa 19
IN - India 18
EU - Europa 14
PL - Polonia 13
IE - Irlanda 12
IR - Iran 12
NL - Olanda 11
CH - Svizzera 9
BD - Bangladesh 7
ES - Italia 7
JP - Giappone 7
SA - Arabia Saudita 6
A2 - ???statistics.table.value.countryCode.A2??? 5
BG - Bulgaria 5
HU - Ungheria 5
LT - Lituania 5
LU - Lussemburgo 5
PT - Portogallo 5
HK - Hong Kong 4
IL - Israele 4
MA - Marocco 4
MD - Moldavia 4
MX - Messico 4
PH - Filippine 4
SK - Slovacchia (Repubblica Slovacca) 4
NG - Nigeria 3
PK - Pakistan 3
RS - Serbia 3
TN - Tunisia 3
CL - Cile 2
DO - Repubblica Dominicana 2
EC - Ecuador 2
IQ - Iraq 2
MK - Macedonia 2
MZ - Mozambico 2
TW - Taiwan 2
AL - Albania 1
AO - Angola 1
AR - Argentina 1
AT - Austria 1
AZ - Azerbaigian 1
BT - Bhutan 1
BW - Botswana 1
GR - Grecia 1
JO - Giordania 1
LV - Lettonia 1
ML - Mali 1
MY - Malesia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
PY - Paraguay 1
SL - Sierra Leone 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZA - Sudafrica 1
ZM - Zambia 1
Totale 10.664
Salva come PNG Salva come JPEG
Città #
Chandler 1.265
Singapore 596
Jacksonville 577
Princeton 396
New York 232
Nanjing 192
Dearborn 190
Wilmington 155
Rome 152
Sassari 150
Ann Arbor 106
Boardman 95
Nanchang 82
Beijing 76
Milan 76
Munich 73
Shenyang 70
Ashburn 68
Santa Clara 59
Brno 56
Tianjin 47
Woodbridge 47
Hebei 43
Helsinki 43
Changsha 40
Cagliari 39
Naples 36
Brussels 35
Jinan 35
Seoul 28
Jiaxing 27
Toronto 27
Dallas 26
Ningbo 26
Zhengzhou 26
Guangzhou 25
Norwalk 25
Andover 23
Turin 23
Florence 22
Kunming 21
Taizhou 20
Falls Church 19
Mountain View 19
Izmir 18
San Francisco 18
Bologna 17
Hangzhou 16
Palermo 14
Auburn Hills 13
Changchun 12
London 12
Los Angeles 12
Romola 12
Sydney 12
Dublin 11
Frankfurt am Main 11
Lanzhou 11
Genoa 10
Leawood 10
Ardabil 9
Brescia 9
Lappeenranta 9
San Mateo 9
Shanghai 9
Washington 9
Edinburgh 8
Gonnosfanàdiga 8
Verona 8
Alghero 7
Bari 7
Horia 7
Napoli 7
São Paulo 7
Catania 6
Ottawa 6
Pescara 6
Ravenna 6
Rivalta di Torino 6
São Bernardo do Campo 6
Augusta 5
Canberra 5
Città Di Castello 5
Cosenza 5
Haikou 5
Hefei 5
Houston 5
Istanbul 5
Monza 5
Belo Horizonte 4
Briosco 4
Budapest 4
Cernusco sul Naviglio 4
Chisinau 4
Iesi 4
Lanciano 4
Luxembourg 4
Novara 4
Padova 4
Paris 4
Totale 5.835
Salva come PNG Salva come JPEG
Nome #
CASE REPORT: MIOCARDITE ACUTA DA CITOMEGALOVIRUS IN GIOVANE PAZIENTE IMMUNOCOMPETENTE 1.262
PARVOVIRUS B19 E POLIMIALGIA REUMATICA: THE BUTTERFLY EFFECT 175
Enzyme biosensors for biomedical applications: Strategies for safeguarding analytical performances in biological fluids 118
Underserved populations and bacterial and protozoal sexually transmitted infections: a lost health-care opportunity 93
Meningite linfomatosa in un paziente con linfoma plasmoblastico del cavo orale HIV-relato: ruolo della citarabina liposomiale. 91
The burden of HIV-Associated neurocognitive disorder (HAND) in post-HAART era: Amultidisciplinary review of the literature 90
Alendronate reduces bone resorption in HIV-associated osteopenia/osteoporosis 89
Ebola virus disease: Case management in the Institute of Infectious Diseases, University Hospital of Sassari, Sardinia, Italy. 85
HEPATOCELLULAR CARCINOMA DEVELOPMENT IN A PATIENT WITH HCV INFECTION AFTER ERADICATION WITH DIRECT-ACTING ANTIVIRAL AGENTS 80
Targeted therapies in cholangiocarcinoma: emerging evidence from clinical trials 77
Tenofovir renal safety in HIV-infected patients: results from the SCOLTA Project 75
Activation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: the missing link with multiple sclerosis? 75
Hepatic echinococcosis: clinical and therapeutic aspects. 75
Trends in the European HIV/AIDS epidemic: a perspective from Italy 74
Objective evaluation of anosmia and ageusia in COVID-19 patients: Single-center experience on 72 cases 72
Utilizzo di EVG/COBI/FTC/TDF in una paziente con viremia elevata e cirrosi HCV-correlata 71
Somatostatin receptor scintigraphy in liver metastasis detection from gastroenteropancreatic neuroendocrine tumors 70
The use of nucleoside reverse transcriptase inhibitors sparing regimens in treatment-experienced HIV-1 infected patients 69
Kidney disease in HIV-infected patients. 68
Immune response induced by Epstein-Barr virus and Mycobacterium avium subsp. paratuberculosis peptides in current and past infectious mononucleosis: a risk for multiple sclerosis? 68
Natalizumab therapy modulates miR-155, miR-26a and proinflammatory cytokine expression in MS patients 67
Activation of endogenous retroviruses of the HERV-W family by Epstein Barr virus in vitro and in vivo: a dual virus model as the missing link with multiple sclerosis 67
Clinical features, laboratory findings and predictors of death in hospitalized patients with COVID-19 in Sardinia, Italy 66
99mTc-tetrofosmin SPECT in solitary pulmonary nodule evaluation 65
A case of vasculitis-like skin eruption associated with COVID-19 65
Different impact of NNRTI and PI-including HAART on bone mineral density loss in HIV-infected patients 65
Bone mass loss and vitamin D metabolism impairment in HIV patients receiving highly active antiretroviral therapy 64
Mucocutaneous leishmniasis as presentation of HIV infection in Sardinia, insular Italy 64
Is metabolic syndrome associated to HIV infection per se? Results from the HERMES study 64
Editorial - Non AIDS-defining malignancies: a new epidemic in HIV-infected population for the upcoming decades? 64
Adverse skin reactions in course of combined antiretroviral therapy 64
Active Case Finding for Communicable Diseases in Prison Settings: Increasing Testing Coverage and Uptake Among the Prison Population in the European Union/European Economic Area 63
Proteomic characterization of hepatitis C eradication: enzyme switch in the healing liver. 62
Epidemiology, Clinical Aspects, Laboratory Diagnosis and Treatment of Rickettsial Diseases in the Mediterranean Area During COVID-19 Pandemic: A Review of the Literature 62
Alexithymia Predicts Carotid Atherosclerosis, Vascular Events, and All-Cause Mortality in Human Immunodeficiency Virus-Infected Patients: An Italian Multisite Prospective Cohort Study 61
Analisi delle Dual Therapy nei pazienti con HIV: Aspetti farmacoeconomici-epidemiologici e clinici 61
Somatostatin receptor scintigraphy with 111In-pentetreotide in non-functioning gastroenteropancreatic neuroendocrine tumors 60
Identifying HIV patients with an unfavorable cardiovascular risk profile in the clinical practice: results from the SIMONE study 60
Mediterranean spotted fever-like illness in Sardinia, Italy: a clinical and microbiological study 60
Mitochondrial toxicity and body shape changes during nucleos(t)ide analogues administration in patients with chronic hepatitis B 60
The usefulness of 99mTc tetrofosmin scintigraphy in patients with breast cancer recurrences 59
The usefulness of 99mTc-tetrofosmin SPECT in the detection of intrathoracic malignant lesions 59
The HIV treatment and care cascade in Italy: successes and disparities 59
Body fat changes in HIV patients on highly active antiretroviral therapy (HAART): a longitudinal DEXA study. 58
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial. 58
LPS and HIV gp120 modulate monocyte/macrophage CYP27B1 and CYP24A1 expression leading to vitamin D consumption and hypovitaminosis D in HIV-infected individuals. 58
EFFICACIA A TOLLERABILITÀ DELLA DUAL THERAPY RALTEGRAVIR+DARUNAVIR/RITONAVIR NELLA PRATICA CLINICA 58
Body composition change in hiv-infected patients treated with HAART: a longitudinal DEXA study. 58
Bacterial community acquired pneumonia in HIV-infected inpatients in the highly active antiretroviral therapy era 57
Tache Noire in a Patient with Acute Q Fever 57
Olfactory and gustatory function impairment in COVID-19 patients: Italian objective multicenter-study 57
Rhino-maxillary and orbital mucormycosis in a patient with acute myeloid leukaemia:a successful surgery and antifungal therapy combined approach 57
COBI: I DATI DI EFFICACIA IN CO-FORMULAZIONE CON ELVITEGRAVIR 56
The feature of Metabolic Syndrome in HIV naive patients is not the same of those treated: results from a prospective study. 56
Simplification to atazanavir/ritonavir+lamivudine in virologically suppressed HIV-infected patients: 24-weeks interim analysis from ATLAS-M trial. 56
Pneumococcal pneumonia: clinical features, diagnosis and management in HIV-infected and HIV non infected patients 56
Patient-Reported Outcomes in an Observational Cohort of HIV-1-Infected Adults on Darunavir/Cobicistat-Based Regimens: Beyond Viral Suppression 56
The additional role of 18F-FDG PET/CT in prosthetic valve endocarditis 56
The monitoring and the management of adverse events: a new challenge in the treatment of HIV infection: results from a cohort study. 56
Impact of genotypic susceptibility score on cART outcomes during primary HIV infection 55
QuantiFERON TB Gold: a new method for latent tuberculosis infection 55
DNMT1 modulation in chronic hepatitis B patients and hypothetic influence on mitochondrial DNA methylation status during long-term nucleo(t)side analogs therapy 55
The changing face of the HIV epidemic in Northern Sardinia: increased diagnoses among pregnant women 55
Drug-resistant disseminated polyclonal Mycobacterium avium complex in a patient with AIDS: a case report and review of the literature 55
Arboviral infections in Egyptian and Sardinian children and adults with aseptic meningitis and meningo-encephalitis 54
Cytological and histological diagnosis of lung cancer in Sardinia and Italy in the 1990s 54
Durability of lopinavir/ritonavir dual-therapies in individuals with viral load <50 copies/mL in the observational setting. 54
Acute respiratory distress syndrome due to influenza virus A/H1N1v in a patient with HIV/HCV co-infection 54
Myalgia and phosphokinase elevations in the HAART era: focus on Raltegravir. 53
Usefulness of 99mTc-tetrofosmin scintigraphy in different variants of Kaposi's sarcoma. 52
CD4 cell count and the risk of infective and non-infective serious non-AIDS events in HIV-positive persons seen for care in Italy. 52
Low High-density Lipoprotein Cholesterol (HDL) is Associated with the Risk of Non-AIDS Defining Malignancies 52
Tuberculosis Screening before Anti–Hepatitis C Virus Therapy in Prisons 51
Body fat changes in HIV patients on highly active antiretroviral therapy (HAART): a longitudinal DEXA study 51
The De Ritis ratio as prognostic biomarker of in-hospital mortality in COVID-19 patients 51
Safety and durability in a cohort of HIV-1 positive patients treated with once and twice daily darunavir-based therapy (SCOLTA Project). 50
Body composition evaluation by DEXA in the follow up of HIV patients treted with HAART. 50
Longitudinal analysis of HIV-1 coreceptor tropism by single and triplicate HIV-1 RNA and DNA sequencing in patients undergoing successful first-line antiretroviral therapy 49
Physician Attitudes and Perceptions of Complementary and Alternative Medicine (CAM): A Multicentre Italian Study 49
Bacterial community-acquired pneumonia in HIV-infected patients 49
Smoking habits in HIV-infected people compared with the general population in Italy: a cross-sectional study 48
Dalbavancin two dose regimen for the treatment of prosthetic joint infections: new possible options for difficult to treat infectious diseases 48
CAIDE risk score predicts atherosclerosis and vascular events in HIV patients. Preliminary data from the Italian multicentre cohort of CARdiovascular and late-life Dementia risk in HIV (CARDH) Study 48
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: An observational cohort study 48
Time trend in hypertension prevalence, awareness, treatment, and control in a contemporary cohort of HIV-infected patients: the HIV and Hypertension Study 48
Body fat changes and mitochondrial alterations during HBV treatment: A warning for long term administration. 47
Lipid profile improvement in virologically suppressed hiv-1-infected patients switched to dolutegravir/ abacavir/lamivudine: Data from the SCOLTA project 47
Hepatitis E virus and hepatitis A virus exposures in an apparently healthy high-risk population in Italy. 47
The usefulness of 99mTc-tetrofosmin SPECT in monitoring the response to chemotherapy in lung cancer patients 47
Co-administration of ritonavir-boosted protease inhibitors and rate of tenofovir discontinuation in clinical practice. 46
Positioning of darunavir/cobicistat-containing antiretroviral regimens in real life: Results from a large multicentre observational prospective cohort (SCOLTA) 46
Does Angiotensin II receptor blockers increase the risk of SARS-CoV-2 infection? A real-life experience 46
Treatment with direct-acting antivirals in a multicenter cohort of HCV-infected inmates in Italy 46
Bone safety of dolutegravir-containing regimens in people living with HIV: Results from a real-world cohort 46
Efficacy and safety of boosted and unboosted atazanavir-containing antiretroviral regimens in real life: results from a multicentre cohort study 46
Prevalence, awareness, treatment, and control rate of hypertension in HIV-infected patients: The HIV-HY study 46
FATTORI ASSOCIATI A RIDUZIONE DELLE PRESTAZIONI MNESICHE IN UNA COORTE POLICENTRICA DI PAZIENTI CON INFEZIONE DA HIV. DATI PRELIMINARI DEL COGNITIVE SUBSTUDY: PROGETTO “ALESSITIMIA E RISCHIO CARDIOVASCOLARE IN HIV” 46
Body fat distribution changes and highly active antiretroviral therapy (HAART): a clinical study in HIV patients 46
A longitudinal Study on body compositionin HIV –infected patients receiving HAART. 46
Rickettsia monacensis as Cause of Mediterranean Spotted Fever-like Illness, Italy 45
Totale 7.261
Salva come PNG Salva come JPEG
Categoria #
all - tutte 61.508
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.508
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020929 0 0 0 0 0 176 287 29 181 69 167 20
2020/20211.498 169 13 212 12 179 67 187 52 271 224 76 36
2021/20221.109 130 29 26 26 26 32 40 63 83 72 143 439
2022/20232.522 239 209 68 414 208 404 37 274 402 47 130 90
2023/20241.209 139 72 56 40 293 114 35 79 17 48 101 215
2024/20251.625 150 144 492 309 494 36 0 0 0 0 0 0
Totale 11.154